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Commercially available materials were used as received without further purification. All reactions were performed using common inert 
atmosphere techniques, unless otherwise mentioned. Reactions were monitored by analytical thin-layer chromatography (TLC) using 
Merck 60 F254 precoated silica gel plates. Solvents were purified by SciMatCo solvent purification system. Amines were purified by 
Innovative Technology purification system. Photocatalytic reactions were irradiated with one Kessil H350 lamp, placed in a distance of 
5 cm from the reaction vessel. HPLC analysis of reaction mixtures was performed by a Waters ACQUITY UPLC system with PDA UV-
Vis detector. Nuclear magnetic resonance (NMR) spectra were recorded on a Varian MR400 400 MHz and Varian vnmrs 500 MHz 
spectrometer. Chemical shifts (δ) are reported in parts per million (ppm) and referenced to chloroform (1H: δ = 7.26 ppm, 13C: 77.16 
ppm). 1H-NMR splitting patterns are designated as singlet (s), doublet (d), triplet (t), quartet (q), pentet (p), multiplet (m). Mass spectra 
were recorded at the Mass Spectrometry Facility at the Department of Chemistry of the University of Michigan in Ann Arbor, MI on an 
Agilent Q-TOF HPLC-MS with ESI high resolution mass spectrometer. 
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Additional Optimization Data 
Table S1. Additional data for the optimization of Smiles reaction of 3a. 
 
Entry Variation of above condtions Yield 2a (%)[a] 
1 None >95 (87) 
2 1.0 mol% [Ru(bpy)3](PF6)2 II 44 
3 1.0 mol% [Ir(ppy)3] III 81 
4 10 mol% Phenylphenothiazine IV 29 
5 5 mol% 4CzIPN V >95 (83) 
6 0.1 mol% IrOG 93 
7 0.01 mol% IrOG 67 
8 0.1 mol% [Ir(ppy)2dtbbpy]PF6 91 
9 5.0 eq. Et3N 54 
10 under air 0 
11 No base 0 
12 No catalyst 11 
13 Exclusion of light 0 
14 No catalyst, no irradiation, 60 °C 0 




Table S2. Additional data for the optimization of Finkelstein/Smiles reaction of 5a. 
 
Entry Variation of above conditions Yield 2a (%)[a] 
1 none 0, see Scheme S1 
2 1.0 eq. NaI 55 
3 1.0 eq. NaI, 60 °C >95 
4 0.2 eq. NaI, 60 °C 16 
5 0.5 eq. NaI, 60 °C >95 
6 1.0 eq. NaI, MeCN/H2O 9:1, 60 °C 50 
7 0.5 eq. NaI, 60 °C, DMF (0.1 M) 74 
8 0.5 eq. NaI, 60 °C, DMSO (0.1 M) 68 
9 1.0 eq. Bu4NI, 60 °C >95 
10 0.2 eq. Bu4NI, 60 °C 17 
11 0.5 eq. NaI, 3.0 eq. iPr2NEt, 60 °C >95 
12 0.5 eq. NaI, 3.0 eq. Et3N, 60 °C 26, see Scheme S2 
13 0.5 eq. NaI, 3.0 eq. iPr2NEt, 40 °C, 0.1 M 61 
14 0.5 eq. NaI, 3.0 eq. iPr2NEt, 60 °C, 0.2 M >95 
15 0.5 eq. NaI, 3.0 eq. iPr2NEt, 60 °C, 0.3 M,  90 
16 0.5 eq. NaI, 3.0 eq. iPr2NEt, 60 °C, 0.4 M 57 
[a] determined by HPLC analysis; isolated yield in parentheses. 




Scheme S1. Reactivity of 7a in absence of an iodide-source (Table S1, Entry 1). 
S-1: 1H-NMR (CDCl3, 400 MHz) δ 1.01, t, J = 7.3 Hz, 3 H, CH3), 1.72 (sextet, J = 7.3 Hz, 2 H, CH2), 3.20 (q, J = 6.7 Hz, 2 H, CH2), 3.79 
(s, 3 H, OCH3), 6.14 (d, J = 5.7 Hz, 1 H, Ar), 7.01 (d, J = 5.7 Hz, 1 H, Ar), 7.43 (br s, 1 H, NH) ppm. 
S-2: 1H-NMR (CDCl3, 400 MHz) δ 1.97 (p, J = 7.0 Hz, 2 H, CH2), 2.32 (s, 3 H, CH3), 2.97 (t, J = 7.0 Hz, 2 H, CH2), 3.36 (q, J = 6.5 Hz, 
2 H, CH2), 3.79 (s, 3 H, OCH3), 6.16 (d, J = 5.7 Hz, 1 H, Ar), 7.01 (d, J = 5.7 Hz, 1 H, Ar), 7.10 (d, J = 8.0 Hz, 2 H, Ts), 7.27 (d, J = 8.0 
Hz, 2 H, Ts), 7.42 (br s, 1 H, NH) ppm. 
 
Scheme S2. Reaction of 7a in presence of photocatalyst I and Et3N (Table S1, Entry 11). 
S-3: 1H-NMR (CDCl3, 400 MHz) δ 1.37 (t, J = 7.2 Hz, 9 H, CH3), 2.21 (mc, 2 H, CH2), 2.42 (s, 3 H, CH3), 3.50 (q, J = 7.2 Hz, 6 H, 
CH2), 3.61-3.86 (m, 7 H, CH2, OCH3), 7.17 (d, J = 5.8 Hz, 1 H, Ar), 7.25-7.30 (m, 3 H, Ar, Ts), 7.48 (d, J = 8.2 Hz, 2 H, Ts) ppm. 
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Additional Mechanistic Aspects 
In the course of our reaction optimization, we observed a small amount of Smiles rearrangement product 2a being formed in absence 
of any photocatalyst (Table S1, Entry 12). Also, we noticed a slightly enhanced reaction rate under an aerobic atmosphere for the 
iridium-mediated reaction (Figure S1). These findings suggest that alternative pathways to primary alkyl radical 11 contribute to the 
overall reaction rate. As photolysis of the alkyl iodide does not occur in absence of an amine base, the combination of both might lead 
to the formation of an EDA complex, that is able to undergo charge transfer from upon irradiation. [1] The increased reaction rate under 
aerobic conditions suggests a pathway that is mediated by the amino radical cation of iPr2NEt. It is supposedly generated by single 
electron oxidation by molecular oxygen and might abstract the iodine atom of 3a to generate 11 (Scheme S3). This hypothesis is 
supported by the result of the electrochemical experiment depicted in Scheme S4. Herein, a potential of +1.0 V was applied to a solution 
of 3a in presence of iPr2NEt and Bu4NPF6 as the electrolyte, and Smiles product 2a was achieved in 20% yield. 
 
Figure S1. Time resolution of Finkelstein/Smiles reaction of 7a under oxygen-free conditions and air atmosphere. Conditions: 1.0 mol% 
[Ir(ppy)2(dtbbpy)]PF6, 3.0 equivalents iPr2NEt, 0.5 equivaents NaI, MeCN (c = 0.1 M). 
 
 
Scheme S3. Algternative pathways to key radical intermediate 11. 
 
Scheme S4. Electrochemical conduction of Smiles rearrangemen 
_______________ 
[1] a) A. Böhm, T. Bach, Chem. Eur. J. 2016, 22, 15921; b) J. F. Franz, W. B. Kraus, K. Zeitler, Chem. Commun. 2015, 51, 8280; 
c) D. P. Stevenson, G. M. Coppinger, J. Am. Chem. Soc. 1962, 84, 149 
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Synthesis of Substrates 
 
General procedure for the sulfonylation of amines (GP1): Commercially available amines (1.0 equiv.) were dissolved in CH2Cl2 (0.4 
M) in an oven dried round bottom flask equipped with stir bar and sulfonyl chloride (1.15 equiv.) and pyridine (3.0 equiv.) were added 
at RT and it was stirred for the indicated time. The reaction mixture was poured into 1 N HCl/CH2Cl2 and extracted with CH2Cl2 (3x), 
dried over Na2SO4 and concentrated. Pure sulfonamides S-4 were obtained by column chromatography using silica and hexanes/EtOAc. 
 
General Procedure for the bromoalkylation of protected amines S-1 with dibromoalkanes (GP2): To a solution of sulfonamides 
S-4 in DMF (0.07 M) in an oven dried round bottom flask was added K2CO3 (5.0 equiv.) and dibromoalkane (10 equiv.) and heated to 
60 °C for the indicated time. After cooling to RT, it was poured into H2O/EtOAc and extracted with EtOAc (3x). The combined organic 
layers were washed with 1 N HCl (1x) and 1 M LiCl (3x), dried over Na2SO4 and concentrated. Pure alkylbromides 7 were obtained by 
column chromatography using silica and hexanes/EtOAc. 
methyl 2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate S-4a 
 
Synthesis according to GP1: 3.14 g (20.0 mmol) methyl 2-aminothiophene-3-carboxylate, 4.39 g (23.0 mmol) 4-methylbenzenesulfonyl 
chloride, 4.83 mL (4.75 g, 60.0 mmol) pyridine. Column chromatography hexanes/EtOAc 3:1 gave 4.94 g (15.9 mmol, 79%) of S-4a as 
a light brown solid. Rf = 0.35 (hexanes/EtOAc 2:1), 1H-NMR (CDCl3, 400 MHz) δ 2.37 (s, 3 H, CH3), 3.79 (s, 3 H, OCH3), 6.64 (d, J = 
5.8 Hz, 1 H, Ar), 7.06 (d, J = 5.8 Hz, 1 H, Ar), 7.25 (d, J = 8.3 Hz, 2 H, Ts), 7.79 (d, J = 8.3 Hz, 2 H, Ts), 10.12 (s, 1 H, NH) ppm. 13C-
NMR (CDCl3, 100 MHz) δ 21.7, 51.9, 114.2, 115.7, 124.9, 127.4, 129.9, 135.9, 144.7, 150.0, 165.4 ppm. 
methyl 2-((4-(trifluoromethyl)phenyl)sulfonamido)thiophene-3-carboxylate S-4b 
 
Synthesis according to GP1: 786 mg (5.00 mmol) methyl 2-aminothiophene-3-carboxylate, 1.35 g (5.50 mmol) 
4-(trifluoromethyl)benzenesulfonyl chloride, 1.21 mL (1.19 g, 15.0 mmol) pyridine. Column chromatography hexanes/EtOAc 5:1 → 3:1 
gave 581 mg (1.59 mmol, 32%) of S-4b as a colorless solid. Rf = 0.40 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 3.81 (s, 3 H, 
OCH3), 6.70 (d, J = 5.8 Hz, 1 H, Ar), 7.09 (d, J = 5.8 Hz, 1 H, Ar), 7.74 (d, J = 8.4 Hz, 1 H, Ts), 8.04 (d, J = 8.4 Hz, 1 H, Ts), 10.25 (s, 
1 H, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 52.1, 115.0, 116.3, 123.2 (q, JC,F = 273 Hz), 125.1, 126.5 (q, JC,F = 3.7 Hz), 127.9, 135.3 
(q, JC,F = 33 Hz), 142.3, 148.9, 165.5 ppm. 
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methyl 2-((tert-butoxycarbonyl)amino)thiophene-3-carboxylate S-4c 
 
480 mg (2.2 mmol) Boc2O in an oven dried round bottom flask was dissolved in 50 mL of 1,4-dioxane, 3.14 mg (2.00 mmol) methyl 
2-aminothiophene-3-carboxylate and 24.4 mg (0.10 mmol) DMAP were added and it was stirred at RT for 2 h. The reaction mixture 
was poured into water/EtOAc, extracted with EtOAc (3x) and the combined organic phases were dried over Na2SO4 and concentrated. 
Purification by column chromatography using hexanes/EtOAc 10:1 → 5:1 gave 403 mg (1.57 mmol, 78%) of S-4c as a colorless oil. Rf 
= 0.30 (hexanes/EtOAc 9:1). 1H-NMR (CDCl3, 400 MHz) δ 1.53 (s, 9 H, Boc), 3.86 (s, 3 H, OCH3), 6.64 (d, J = 5.8 Hz, 1 H, Ar), 7.13 
(d, J = 5.8 Hz, 1 H, Ar), 10.03 (s, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 28.3, 51.7, 82.3, 111.1, 114.7, 124.2, 151.3, 152.2, 165.9 
ppm. 
ethyl 4,5-dimethyl-2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate S-4f 
 
Synthesis according to GP1: 399 mg (2.00 mmol) ethyl 2-amino-4,5-dimethylthiophene-3-carboxylate, 438 mg (2.30 mmol) 
4-methylbenzenesulfonyl chloride, 0.485 mL (475 mg, 6.00 mmol) pyridine. Column chromatography hexanes/EtOAc 5:1 → 3:1 gave 
605 mg (1.71 mmol, 86%) of S-4f as a colorless solid. Rf = 0.40 (hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 400 MHz) δ 1.32 (t, J = 7.1 Hz, 
3 H, CH3), 2.13 (s, 3 H, CH3), 2.21 (s, 3 H, CH3), 2.38 (s, 3 H, CH3), 4.25 (q, J = 7.1 Hz, 2 H, OCH2), 7.25 (d, J = 8.1 Hz, 2 H, Ts), 7.77 
(d, J = 8.1 Hz, 2 H, Ts), 10.37 (s, 1 H, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 12.7, 14.3, 14.5, 21.7, 60.8, 114.9, 123.4, 127.4, 129.8, 
130.2, 136.1, 144.3, 147.1, 165.9 ppm. 
ethyl 4-methyl-2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate S-4g 
 
Synthesis according to GP1: 556 mg (3.00 mmol) ethyl 2-amino-4-methylthiophene-3-carboxylate, 658 mg (3.45 mmol) 
4-methylbenzenesulfonyl chloride, 0.728 mL (712 mg, 9.00 mmol) pyridine. Column chromatography hexanes/EtOAc 5:1 → 3:1 gave 
781 mg (2.30 mmol, 77%) of S-4g as a colorless solid. Rf = 0.45 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.33 (t, J = 7.1 Hz, 
3 H, CH3), 2.25 (s, 3 H, CH3), 2.38 (s, 3 H, CH3), 4.27 (q, J = 7.1 Hz, 2 H, OCH2), 6.28 (s, 1 H, Ar), 7.25 (d, J = 8.3 Hz, 1 H, Ts), 7.79 
(d, J = 8.3 Hz, 1 H, Ts), 10.50 (s, 1 H, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 14.3, 18.1, 21.7, 61.0, 112.0, 114.0, 127.4, 129.8, 136.0, 
144.5, 151.1, 165.9 ppm. 
methyl 2-((4-methylphenyl)sulfonamido)-4,5,6,7-tetrahydrobenzothiophene-3-carboxylate S-4h 
 
Synthesis according to GP1: 423 mg (2.00 mmol) methyl 2-amino-4,5,6,7-tetrahydrobenzothiophene-3-carboxylate, 438 mg 
(2.30 mmol) 4-methylbenzenesulfonyl chloride, 0.485 mL (475 mg, 6.00 mmol) pyridine. Column chromatography hexanes/EtOAc 
5:1 → 3:1 gave 446 mg (1.22 mmol, 61%) of S-4h as a colorless solid. Rf = 0.20 (hexanes/EtOAc 4:1). 1H-NMR (CDCl3, 400 MHz) δ 
1.32 1.66-1.79 (m, 4 H, CH2), 2.39 (s, 3 H, CH3), 2.54-2.60 (m, 2 H, CH2), 2.60-2.66 (m, 2 H, CH2), 3.77 (s, 3 H, OCH3), 7.26 (d, J = 8.3 
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Hz, 2 H, Ts), 7.80 (d, J = 8.3 Hz, 2 H, Ts), 10.38 (s, 1 H, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.7, 22.7, 23.0, 24.6, 26.5, 51.6, 
113.2, 126.7, 127.5, 129.9, 132.1, 136.1, 144.4, 148.2, 166.4 ppm. 
5-(tert-butyl) 3-ethyl 2-((4-methylphenyl)sulfonamido)-6,7-dihydrothieno[3,2-c]pyridine-3,5(4H)-dicarboxylate S-4i 
 
Synthesis according to GP1: 625 mg (1.91 mmol) ethyl 2-((4-methylphenyl)sulfonamido)-4,5,6,7-tetrahydrothieno[3,2-c]pyridine-3-
carboxylate, 420 mg (2.20 mmol) 4-methylbenzenesulfonyl chloride, 0.464 mL (454 mg, 5.74 mmol) pyridine. Column chromatography 
hexanes/EtOAc 3:1 → 1:1 gave 782 mg (1.63 mmol, 85%) of S-4i as a colorless foam. Rf = 0.25 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 
400 MHz) δ 1.31 (t, J = 7.1 Hz, 3 H, CH3), 9.84 (s, 9 H, Boc), 2.39 (s, 3 H, CH3), 2.74 (mc, 2 H, CH2), 3.58 (t, J = 5.6 Hz, 2 H, CH2), 
4.25 (q, J = 7.1 Hz, 2 H, OCH2), 4.43 (s, 2 H, CH2), 7.27 (d, J = 8.1 Hz, 2 H, Ts), 7.79 (d, J = 8.1 Hz, 2 H, Ts), 10.43 (s, 1 H, NH) ppm. 
13C-NMR (CDCl3, 100 MHz) δ 14.3, 21.7, 26.8, 28.6, 41.2, 42,7, 61.0, 80.4, 113.1, 123.4, 127.5, 129.9, 131.2, 136.3, 144.6, 149.3, 
154.7, 165.5 ppm. 
N-(3-cyanothiophen-2-yl)-4-methylbenzenesulfonamide S-4j 
 
Synthesis according to GP1: 621 mg (5.00 mmol) 2-aminothiophene-3-carbonitrile, 1.10 g (5.75 mmol) 4-methylbenzenesulfonyl 
chloride, 1.21 mL (1.19 g, 15.0 mmol) pyridine. Column chromatography hexanes/EtOAc 2:1 → 3:2 gave 234 mg (0.54 mmol,11%) of 
S-4j as a colorless oil. Rf = 0.20 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 2.42 (s, 3 H, CH3), 6.91 (d, J = 5.8 Hz, 1 H, Ar), 
6.96 (d, J = 5.8 Hz, 1 H, Ar), 7.30 (d, J = 8.4 Hz, 2 H, Ts), 7.65 (br s, 1 H, NH), 7.74 (d, J = 8.4 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 
MHz) δ 21.8, 100.6, 113.5, 121.3, 125.8, 127.6, 130.2, 134.9, 145.4, 148.9 ppm. 
N-(3-cyanothiophen-2-yl)-4-methylbenzenesulfonamide S-4k 
 
Synthesis according to GP1: 393 mg (2.50 mmol) methyl 3-aminothiophene-2-carboxylate 548 mg (2.87 mmol) 
4-methylbenzenesulfonyl chloride, 1.01 mL (989 mg, 12.5 mmol) pyridine. Column chromatography hexanes/EtOAc 6:1 gave 185 mg 
(0.59 mmol,24%) of S-4k as a colorless oil. 1H-NMR (CDCl3, 400 MHz) δ 2.25 (s, 3 H, CH3), 3.70 (s, 3 H, CH3), 7.12 (d, J = 8.3 Hz, 
2 H, Ts), 7.61 (d, J = 8.3 Hz, 2 H, Ts), 9.46 (s, 1 H, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.5, 52.0, 110.5, 120.5, 127.0, 129.8, 
131.9, 136.4, 143.6, 144.1, 164.2 ppm. 
methyl 2-((4-methylphenyl)sulfonamido)benzoate S-4l 
 
Synthesis according to GP1: 572 mg (4.64 mmol) methoxyaniline, 974 mg (5.11 mmol) 4-methylbenzenesulfonyl chloride, 1.13 mL 
(1.10 g, 13.9 mmol) pyridine. Column chromatography hexanes/EtOAc 5:1 → 4:1 gave 1.24 g (0.59 mmol, 96%) of S-4l as a colorless 
oil. Rf = 0.15 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 2.35 (s, 3 H, CH3) 3.64 (s, 3 H, OCH3), 6.73 (d, J = 7.9 Hz, 1 H, Ar), 
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6.89 (t, J = 7.4 Hz, 1 H, Ar), 6.95-7.11 (m, 2 H, NH, Ar), 7.18 (d, J = 7.6 Hz, 2 H, Ts), 7.51 (s, J = 7.6 Hz, 1 H, Ar), 7.64 (d, J = 7.6 Hz, 
2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.6, 55.7, 110.7, 121.1, 121.2, 125.3, 126.2, 127.4, 129.5, 136.4, 143.7, 149.6 ppm. 
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ethyl 2-((4-methylphenyl)sulfonamido)cyclopent-1-ene-1-carboxylate S-4m 
 
Synthesis according to GP1: 310 mg (2.00 mmol) ethyl 2-aminocyclopentene-1-carboxylate, 438 mg (2.30 mmol) 
4-methylbenzenesulfonyl chloride, 0.485 mL (475 mg, 6.00 mmol) pyridine. Column chromatography hexanes/EtOAc 4:1 → 1:1 gave 
188 mg (0.608 mmol, 30%) of S-4m as a colorless solid. Rf = 0.45 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.27 (t, J = 7.1 Hz, 
3 H, CH3), 1.78, (p, J = 7.6 HZ, 2 H, CH2), 2.41-2.48 (m, 5 H, CH2, CH3), 2.72 (t, J = 7.7 Hz, 2 H, CH2), 4.18 (q, J = 7.1 Hz, 2 H, OCH2), 
7.31 (d, J = 8.3 Hz, 2 H, Ts), 7.77 (d, J = 8.3 Hz, 2 H, Ts), 10.09 (s, 1 H, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 14.5, 20.7, 21.7, 28.8, 
32.6, 60.2, 107.6, 127.2, 130.0, 137.8, 144.2, 152.7, 167.6 ppm. 
ethyl 2-((4-methylphenyl)sulfonamido)cyclohex-1-ene-1-carboxylate S-4n 
 
Synthesis according to GP1: 422 mg (2.49 mmol) ethyl 2-aminocyclopentene-1-carboxylate, 547 mg (2.87 mmol) 
4-methylbenzenesulfonyl chloride, 0.603 mL (592 mg, 7.48 mmol) pyridine. Column chromatography hexanes/EtOAc 9:1 gave 577 mg 
(1.78 mmol, 72%) of S-4n as a colorless solid. Rf = 0.25 (hexanes/EtOAc 9:1). 1H-NMR (CDCl3, 400 MHz) δ 1.27 (t, J = 7.1 Hz, 3 H, 
CH3), 1.50 (mc, 4 H, CH2), 2.19-2.25 (m, 2 H, CH2), 2.40-2.46 (m, 5 H, CH2, CH3), 4.18 (q, J = 7.1 Hz, 2 H, OCH2), 7.29 (d, J = 8.2 Hz, 
2 H, Ts), 7.75 (d, J = 8.2 Hz, 2 H, Ts), 11.60 (s, 1 H, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 14.3, 21.6, 21.7, 21.7, 24.1, 26.6, 60.6, 
105.2, 127.2, 129.9, 138.1, 143.9, 149.6, 170.0 ppm. 
1-(tert-butyl) 3-ethyl 4-((4-methylphenyl)sulfonamido)-5,6-dihydropyridine-1,3(2H)-dicarboxylate S-4o 
 
synthesis according to GP1: 541 mg (2.00 mmol) ethyl 2-aminocyclopentene-1-carboxylate, 438 mg (2.30 mmol) 
4-methylbenzenesulfonyl chloride, 0.485 mL (475 mg, 6.00 mmol) pyridine. Column chromatography hexanes/EtOAc 6:1 → 3:1 gave 
313 mg (0.74 mmol, 37%) of S-4o as a pale yellow foam along with 129 mg (0.477 mmol, 24%) of starting material. Rf = 0.25 
(hexanes/EtOAc 4:1). 1H-NMR (CDCl3, 400 MHz) δ 1.27 (t, J = 7.1 Hz, 3 H, CH3), 1.42 (s, 9 H, Boc), 2.42 (s, 3 H, CH3), 2.54 (mc, 2 H, 
CH2), 3.38 (t, J = 5.8 Hz, 2 H, CH2), 4.03 (br s, 2 H, CH2), 4.19 (q, J = 7.1 Hz, 2 H, OCH2) 7.30 (d, J = 8.2 Hz, 2 H, Ts), 7.74 (d, J = 8.2 
Hz, 2 H, Ts), 11.45 (s, 1 H, NH) ppm.13C-NMR (CDCl3, 100 MHz) δ 14.2, 21.7, 26.3, 28.4, 39.0, 41.4, 61.0, 80.3, 127.1, 130.1, 137.6, 
144.3, 154.3, 167.9 ppm. 
methyl 2-((4-methylphenyl)sulfonamido)benzoate S-4p 
 
synthesis according to GP1: 302 mg (2.00 mmol) methyl 2-aminobenzoate, 438 mg (2.30 mmol) 4-methylbenzenesulfonyl chloride, 
0.485 mL (475 mg, 6.00 mmol) pyridine. Column chromatography hexanes/EtOAc 3:1 → 2:1 gave 491 mg (1.61 mmol, 80%) of S-4p 
as a colorless solid. Rf = 0.35 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 2.35 (s, 3 H, CH3), 3.87 (s, 3 H, OCH3), 7.02 (t, 
J = 7.6 Hz, 1 H, Ar), 7.21 (d, J = 8.1 Hz, 2 H, Ts), 7.44 (t, J = 7.8 Hz, 1 H, Ar), 7.68 (d, J = 8.4 Hz, 1 H, Ar), 7.73 (d, J = 8.1 Hz, 1 H, 
Ts), 7.91 (d, J = 7.9 Hz, 1 H, Ar), 10.61 (s, 1 H, NH) ppm. 
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methyl 4-((4-methylphenyl)sulfonamido)nicotinate S-4q 
 
synthesis according to GP1: 304 mg (2.00 mmol) methyl 4-aminonicotinate, 438 mg (2.30 mmol) 4-methylbenzenesulfonyl chloride, 
0.485 mL (475 mg, 6.00 mmol) pyridine. Column chromatography hexanes/EtOAc 1:1 → 1:2 gave 124 mg (0.405 mmol, 20%) of S-4q 
as a colorless solid. Rf = 0.15 (hexanes/EtOAc 1:2). 1H-NMR (CDCl3, 400 MHz) δ 2.40 (s, 3 H, CH3), 3.96 (s, 3 H, OCH3), 7.30 (d, J = 
8.2 Hz, 2 H, Ts), 7.53 (d, J = 5.9 Hz, 1 H, Ar), 7.84 (d, J = 8.2 Hz, 2 H, Ts), 8.47 (d, J = 5.9 Hz, 1 H, Ar), 9.04 (s, 1 H, Ar), 10.92 (br s, 
1 H, NH) ppm.13C-NMR (CDCl3, 100 MHz) δ 21.8, 52.9, 110.7, 111.0, 127.5, 130.2, 136.1, 145.0, 147.5, 152.7, 154.0, 167.8 ppm. 
methyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)thiophene-3-carboxylate 7a 
 
Synthesis according to GP2: 1.72 g (5.52 mmol) methyl 2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate S-4a, 3.82 g 
(27.6 mmol) K2CO3, 5.60 mL (11.2 g, 55.2 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 3:1 → 2:1 gave 1.64 g 
(3.79 mmol, 67%) of 7a as a colorless solid. Rf = 0.30 (hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 400 MHz) δ 2.14 (mc, 2 H, CH2), 2.42 (s, 
3 H, CH3), 3.50 (t, J = 6.6 Hz, 2 H, CH2), 3.64 (s, 3 H, OCH3), 3.79 (t, J = 6.6 Hz, 2 H, CH2), 7.16 (d, J = 5.9 Hz, 1 H, Ar), 7.27 (d, J = 8.2 
Hz, 2 H, Ts), 7.32 (d, J = 5.9 Hz, 1 H, Ar), 7.58 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.7, 30.2, 32.1, 51.8, 51.9, 
124.0, 128.0, 128.2, 129.6, 130.2, 135.2, 144.1, 146.0, 162.1 ppm. ESI-HRMS for C16H18BrNO4S2, [M+H]+ calc. 431.9933, found 
431.9934. IR: ṽ = 2950 (-C-H), 1715 (C=O), 1435, 1350, 1265, 1160, 1090 cm-1. 
methyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)thiophene-3-carboxylate 7b  
 
Synthesis according to GP2: 550 mg (1.51 mmol) methyl 2-((4-(trifluoromethyl)phenyl)sulfonamido)thiophene-3-carboxylate S-4b, 1.04 
g (7.53 mmol) K2CO3, 1.53 mL (3.04 g, 15.1 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 3:1 → 2:1 gave 1.64 
g (3.79 mmol, 67%) of 7b as a colorless solid. Rf = 0.45 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 2.17 (p, J = 6.6 Hz, 2 H, 
CH2), 3.49 (t, J = 6.5 Hz, 2 H, CH2), 3.57 (s, 3 H, OCH3), 3.87 (t, J = 6.7 Hz, 2 H, CH2), 7.22 (d, J = 5.9 Hz, 1 H, Ar), 7.32 (d, J = 5.9 
Hz, 1 H, Ar), 7.74 (d, J = 8.4 Hz, 2 H, Ts), 7.83 (d, J = 8.4 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 29.9, 32.1, 51.8, 52.1, 123.4 
(JC,F = 273 Hz), 124.6, 126.1 (JC,F = 3.7 Hz), 128.3, 128.5, 129.7, 134.8 (JC,F = 32.7 Hz), 141.8, 145.4, 161.7 ppm. ESI-HRMS for 
C16H15BrF3NO4S2, [M+H]+ calc. 485.9651, found 485.9644. IR: ṽ = 2955 (-C-H), 1720 (C=O), 1360, 1320, 1270, 1170, 1135, 1060 cm-
1. 
SUPPORTING INFORMATION          
11 
 
methyl 2-((3-bromopropyl)(tert-butoxycarbonyl)amino)thiophene-3-carboxylate 7c  
 
Synthesis according to GP2: 400 mg (1.55 mmol) methyl 2-((tert-butoxycarbonyl)amino)thiophene-3-carboxylate S-4c, 1.07 g 
(7.77 mmol) K2CO3, 1.58 mL (3.14 g, 15.5 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 10:1 → 4:1 gave 440 
mg (1.16 mmol, 75%) of 7c as a colorless oil. Rf = 0.40 (hexanes/EtOAc 4:1). 1H-NMR (CDCl3, 400 MHz) δ 1.20-1.60 (m, 9 H, Boc), 
2.16 (p, J = 6.8 Hz, 2 H, CH2), 3.44 (t, J = 6.7 Hz, 2 H, CH2), 3.76 (t, J = 6.8 Hz, 2 H, CH2), 3.81 (s, 3 H, OCH3), 7.05 (d, J = 5.8 Hz, 1 
H, Ar), 7.30 (d, J = 5.8 Hz, 1 H, Ar) ppm. 13C-NMR (CDCl3, 100 MHz) δ 28.2, 30.7, 31.6, 50.5, 51.9, 81.2, 121.5, 127.5, 127.7, 151.2, 
154.0, 162.5 ppm. ESI-HRMS for C14H20BrNO4S2, [M+Na]+ calc. 400.0189, found 400.0183. IR: ṽ = 2975 (-C-H), 1705 (C=O), 1365, 
1260, 1145 cm-1. 
methyl 2-((N-(3-bromobutyl)-4-methylphenyl)sulfonamido)thiophene-3-carboxylate 7d 
 
Synthesis according to GP2: 623 mg (2.00 mmol) methyl 2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate S-4a, 1.38 g 
(10.0 mmol) K2CO3, 2.36 mL (4.32 g, 20.0 mmol) 1,3-dibromobutane. Column chromatography hexanes/EtOAc 8:1 → 3:1 gave 511 mg 
(1.14 mmol, 57%) of 7d as a colorless oil. Rf = 0.35 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.72 (p, J = 7.2 Hz, 2 H, CH2), 
1.97(p, J = 7.1 Hz, 2 H, CH2), 2.42 (s, 3 H, CH3), 3.40 (t, J = 6.6 Hz, 2 H, CH2), 3.63 (s, 3 H, OCH3), 3.71 (t, J = 6.9 Hz, 2 H, CH2), 7.15 
(d, J = 5.9 Hz, 1 H, Ar), 7.25 (d, J = 8.1 Hz, 2 H, Ts), 7.32 (d, J = 5.9 Hz, 1 H, Ar), 7.58 (d, J = 8.1 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 
100 MHz) δ 21.5, 27.2, 29.6, 33.0, 51.6, 52.1, 123.8, 127.9, 128.1, 129.5, 130.1, 135.6, 143.8, 146.0, 162.0 ppm. ESI-HRMS for 
C17H20BrNO4S2, [M+H]+ calc. 446.0090, found 446.0088. IR: ṽ = 2950 (-C-H), 1715 (C=O), 1435, 1350, 1285, 1155, 1090 cm-1. 
methyl 2-((N-(2-(bromomethyl)allyl)-4-methylphenyl)sulfonamido)thiophene-3-carboxylate 7e 
 
Synthesis according to GP2: 167 mg (0.536 mmol) methyl 2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate S-4a, 371 mg (2.68 
mmol) K2CO3, 5.74 mg (2.68 mmol) 3-bromo-2-(bromomethyl)prop-1-ene. Column chromatography hexanes/EtOAc 8:1 → 1:1 gave 
58.9 mg (0.144 mmol, 27%) of 7e as a colorless oil. Rf = 0.25 (hexanes/EtOAc2:1). 1H-NMR (CDCl3, 400 MHz) δ 2.40 (s, 3 H, CH3), 
3.62 (s, 3 H, OCH3), 4.05 (s, 2 H, CH2), 4.37 (s, 2 H, CH2), 5.07 (s, 1 H, =CH2), 5.25 (s, 1 H, =CH2), 7.11 (d, J = 5.9 Hz, 1 H, Ar), 7.22 
– 7.29 (m, 3 H, Ar, Ts), 7.58 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.7, 33.3, 51.8, 55.3, 120.3, 123.8, 128.0, 
128.1, 129.6, 129.9, 135.0, 140.3, 144.2, 145.8, 162.1 ppm. 
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ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)-4,5-dimethylthiophene-3-carboxylate 7f 
 
Synthesis according to GP2: 527 mg (1.49 mmol) ethyl 4,5-dimethyl-2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate S-4f, 
1.03 g (7.45 mmol) K2CO3, 1.51 mL (3.01 g, 14.9 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 5:1 → 3:1 gave 
505 mg (1.06 mmol, 71%) of 7f as a colorless oil. Rf = 0.35 (hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 400 MHz) δ 1.34 (t, J = 7.1 Hz, 3 H, 
CH3), 2.16 (p, J = 6.6 Hz, 2 H, CH2), 2.20 (s, 3 H, CH3), 2.28 (s, 3 H, CH3), 2.42 (s, 3 H, CH3), 3.50 (t, J = 6.6 Hz, 2 H, CH2), 3.67 (mc, 
2 H, CH2), 4.19 (q, J = 7.1 Hz, 2 H, OCH2), 7.27 (d, J = 8.1 Hz, 2 H, Ts), 7.59 (d, J = 8.1 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) 
δ 13.5, 14.3, 21.7, 30.4, 31.8, 51.8, 61.0, 128.1, 129.6, 132.2, 132.7, 132.8, 135.1, 139.6, 143.9, 163.6 ppm. ESI-HRMS for 
C19H24BrNO4S2, [M+H]+ calc. 474.0403, found 474.0401. IR: ṽ = 2925 (-C-H), 1710 (C=O), 1350, 1260, 1165, 1090 cm-1. 
ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)-4-methylthiophene-3-carboxylate 7g 
 
Synthesis according to GP2: 750 mg (2.21 mmol) ethyl 4-methyl-2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate S-4g, 1.53 
g (11.0 mmol) K2CO3, 2.24 mL (4.46 g, 22.1 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 10:1 → 4:1 gave 
846 mg (1.84 mmol, 83%) of 7g as a colorless oil. Rf = 0.20 (hexanes/EtOAc 5:1). 1H-NMR (CDCl3, 400 MHz) δ 1.35 (t, J = 7.1 Hz, 3 H, 
CH3), 2.16 (p, J = 6.6 Hz, 2 H, CH2), 2.34 (s, 3 H, CH3), 2.42 (s, 3 H, CH3), 3.51 (t, J = 6.6 Hz, 2 H, CH2), 3.71 (t, J = 6.2 Hz, 2 H, CH2), 
4.22 (q, J = 7.1 Hz, 2 H, OCH2), 6.78 (s, 1 H, Ar), 7.26 (d, J = 8.3 Hz, 1 H, Ts), 7.57 (d, J = 8.3 Hz, 1 H, Ts) ppm. 13C-NMR (CDCl3, 100 
MHz) δ 14.3, 17.2, 21.7, 30.3, 31.9, 51.8, 61.1, 119.9, 128.1, 129.7, 131.8, 134.8, 137.8, 144.1, 144.7, 163.2 ppm. ESI-HRMS for 
C18H22BrNO4S2, [M+H]+ calc. 460.0246, found 460.0244. IR: ṽ = 2980, 2925 (-C-H), 1715 (C=O), 1355, 1260, 1160, 1090 cm-1 
ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)-4-methylthiophene-3-carboxylate 7h 
 
Synthesis according to GP2: 431 mg (1.18 mmol) methyl 2-((4-methylphenyl)sulfonamido)-4,5,6,7-tetrahydrobenzothiophene-
3carboxylate S-4h, 815 mg (5.90 mmol) K2CO3, 1.20 mL (2.38 g, 11.8 mmol) 1,3-dibromopropane. Column chromatography 
hexanes/EtOAc 7:1 → 3:1 gave 366 mg (0.752 mmol, 64%) of 7h as a colorless solid. Rf = 0.35 (hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 
400 MHz) δ 1.61-1.76 (m, 4 H, CH2), 2.04 (p, J = 6.5 Hz, 2 H, CH2), 2.31 (s, 3 H, CH3), 2.51-2.57 (m, 2 H, CH2), 2.57-2.65 (m, 2 H, 
CH2), 3.38 (t, J = 6.6 Hz, 2 H, CH2) 3.52-3.61 (m, 5 H, CH2, OCH3), 7.16 (d, J = 8.0 Hz, 2 H, Ts), 7.50 (d, J = 8.0 Hz, 2 H, Ts) ppm. 13C-
NMR (CDCl3, 100 MHz) δ 21.7, 22.5, 22.9, 25.3, 25.8, 30.4, 31.9, 51.6, 51.8, 128.1, 129.7, 130.7, 134.8, 135.4, 135.4, 141.4, 143.9, 
163.4 ppm. ESI-HRMS for C20H24BrNO4S2, [M+H]+ calc. 486.0403, found 486.0399. IR: ṽ = 2935, (-C-H), 1715 (C=O), 1350, 1265, 
1245, 1165, 1090 cm-1. 






Synthesis according to GP2: 718 mg (1.49 mmol) 5-(tert-butyl) 3-ethyl 2-((4-methylphenyl)sulfonamido)-6,7-dihydro-
thieno[3,2-c]pyridine-3,5(4H)-dicarboxylate S-4i, 1.03 g (7.47 mmol) K2CO3, 1.52 mL (3.02 g, 14.9 mmol) 1,3-dibromopropane. Column 
chromatography hexanes/EtOAc 3:1 → 2:1 gave 590 mg (0.981 mmol, 66%) of 7i as a pale yellow foam. Rf = 0.35 (hexanes/EtOAc 
2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.30 (t, J = 7.0 Hz, 3 H, CH3), 1.46 (s, 9 H, Boc), 2.14 (mc, 2 H, CH2), 2.40 (s, 3 H, CH3), 2.82 (mc, 2 
H, CH2), 3.44 (t, J = 6.6 Hz, 2 H, CH2), 3.63 (mc, 2 H, CH2), 3.68 (mc, 2 H, CH2), 4.09-4.22 (m, 2 H, CH2), 4.48 (s, 2 H, CH2), 7.25 (d, J 
= 8.0 Hz, 2 H, Ts), 7.58 (d, J = 8.0 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 14.2, 21.6, 26.2, 28.5, 30.0, 31.9, 41.2, 43.0, 52.0, 
60.9, 80.4, 128.1, 129.7, 130.6, 131.7, 133.7, 135.4, 143.1, 144.0, 154.6, 162.3 ppm. ESI-HRMS for C25H33BrN2O6S2, [M+H]+ calc. 
601,1036, found 601.1022. IR: ṽ = 2975 (-C-H), 1695 (C=O), 1420, 1365, 1240, 1165 cm-1. 
N-(3-bromopropyl)-N-(3-cyanothiophen-2-yl)-4-methylbenzenesulfonamide 7j 
 
Synthesis according to GP2: 207 mg (0.744 mmol) N-(3-cyanothiophen-2-yl)-4-methylbenzenesulfonamide S-4j, 514 mg (3.72 mmol) 
K2CO3, 0.754 mL (1.50 g, 7.44 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 3:1 → 2:1 gave 226 mg (0.566 
mmol, 76%) of 7j as a colorless solid. Rf = 0.15 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 2.11 (p, J = 6.5 Hz, 2 H, CH2), 2.45 
(s, 3 H, CH3), 3.46 (t, J = 6.4 Hz, 2 H, CH2), 3.81 (t, J = 6.7 Hz, 2 H, CH2), 7.08 (d, J = 5.8 Hz, 1 H, Ar), 7.29 (d, J = 5.8 Hz, 1 H, Ar), 
7.33 (d, J = 8.2 Hz, 2 H, Ts), 7.65 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.8, 29.5, 31.7, 51.6, 110.7, 113.1, 
126.3, 127.3, 128.2, 130.2, 133.6, 145.2, 150.7 ppm. ESI-HRMS for C16H18BrNO4S2, [M+NH4]+ calc. 416.0097, found 416.0092. IR: 
ṽ = 3110 (=C-H), 2925 (-C-H), 2235 (C≡N), 1355, 1240, 1165, 1090 cm-1. 
methyl 3-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)thiophene-2-carboxylate 7k 
 
Synthesis according to GP2: 100 mg (0.321 mmol) N-(3-cyanothiophen-2-yl)-4-methylbenzenesulfonamide S-4k, 222 mg (1.61 mmol) 
K2CO3, 0.327 mL (648 mg, 3.21 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 3:1 gave 117 mg (0.271 mmol, 
84%) of 7k as a colorless oil. Rf = 0.25 (hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 400 MHz) δ 2.08 (p, J = 6.6 Hz, 2 H, CH2), 2.41 (s, 3 H, 
CH3), 3.48 (t, J = 6.6 Hz, 2 H, CH2), 3.65 (s, 3 H, OCH3), 3.74 (t, J = 6.6 Hz, 2 H, CH2), 6.94 (d, J = 5.3 Hz, 1 H, Ar), 7.24 (d, J = 8.3 
Hz, 2 H, Ts), 7.46 (d, J = 5.3 Hz, 1 H, Ar), 7.54 (d, J = 8.3 Hz, 2 H Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.7, 30.4, 32.6, 50.3, 52.1, 
127.7, 128.9, 129.5, 129.6, 130.0, 136.0, 140.9, 143.7, 160.7 ppm. ESI-HRMS for C16H18BrNO4S2, [M+H]+ calc. 431.9933, found 
431.9933. IR: ṽ = 2950 (-C-H), 1720 (C=O), 1435, 1350, 1260, 1230, 1160, 1090 cm-1. 





Synthesis according to GP2: 1.19 g (4.29 mmol) methyl 2-((4-methylphenyl)sulfonamido)benzoate S-4l, 2.97 g (21.5 mmol) K2CO3, 
4.35 mL (8.66 g, 42.9 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 9:1 → 3:1 gave 117 mg (0.271 mmol, 
84%) of 7l as a colorless solid. Rf = 0.30 (hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 400 MHz) δ 1.99 (p, J = 6.7 Hz, 2 H, CH2), 2.39 (s, 
3 H, CH3), 3.41 (s, 3 H, OCH3), 3.45 (t, J = 6.7 Hz, 2 H, CH2), 3.68 (mc, 2 H, CH2), 6.79 (d, J = 8.3 Hz, 1 H, Ar), 6.91 (t, J = 7.5 Hz, 1 H, 
Ar), 7.19 (d, J = 7.6 Hz, 1 H, Ar), 7.22 (d, J = 8.2 Hz, 2 H, Ts), 7.28 (t, J = 7.7 Hz, 1 H, Ar), 7.54 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR 
(CDCl3, 100 MHz) δ 21.6, 30.6, 32.4, 48.9, 55.1, 111.9, 120.9, 126.9, 127.8, 129.2, 130.1, 132.8, 137.2, 143.0, 156.8 ppm. ESI-HRMS 
for C17H20BrNO3S, [M+H]+ calc. 398.0420, found 398.0419. IR: ṽ = 2940 (-C-H), 1495, 1340, 1255, 1155, 1090, 1025 cm-1. 
ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)cyclopent-1-ene-1-carboxylate 7m 
 
Synthesis according to GP2: 127 mg (0.410 mmol) ethyl 2-((4-methylphenyl)sulfonamido)cyclopent-1-ene-1-carboxylate S-4m, 284 mg 
(2.05 mmol) K2CO3, 0.416 mL (829 mg, 4.10 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 5:1 → 2:1 gave 
117 mg (0.271 mmol, 84%) of 7m as a colorless solid. Rf = 0.45 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.25 (t, J = 7.1 Hz, 
3 H, CH3), 1.86, (p, J = 7.6 Hz, 2 H, CH2), 2.10 (p, J = 6.4 Hz, 2 H, CH2), 2.36-2.47 (m, 5 H, CH2, CH3), 2.68 (mc, 2 H, CH2), 3.49 (t, J 
= 6.4Hz, 2 H, CH3), 3.56 (t, J = 6.5 Hz, 2 H, CH2), 4.09 (q, J = 7.1 Hz, 2 H, OCH2), 7.28 (d, J = 8.3 Hz, 2 H, Ts), 7.68 (d, J = 8.3Hz, 2 
H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 14.2, 20.6, 21.7, 30.7, 32.3, 32.6, 34.7, 47.7, 60.5, 127.5, 129.7, 131.6, 136.8, 143.7, 146.1, 
164.5 ppm. ESI-HRMS for C18H24BrNO4S, [M+H]+ calc. 430.0682, found 430.0682. IR: ṽ = 2960 (-C-H), 1710 (C=O), 1350, 1235, 1160, 
1090 cm-1. 
ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)cyclohex-1-ene-1-carboxylate 7n 
 
Synthesis according to GP2: 323 mg (1.00 mmol) ethyl 2-((4-methylphenyl)sulfonamido)cyclohex-1-ene-1-carboxylate S-4n, 691 mg 
(5.00 mmol) K2CO3, 1.01 mL (2.02 g, 10.0 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 8:1 → 3:1 gave 393 
mg (0.884 mmol, 88%) of 7n as a colorless solid. Rf = 0.20 (hexanes/EtOAc 4:1). 1H-NMR (CDCl3, 400 MHz) δ 1.28 (t, J = 7.1 Hz, 3 H, 
CH3), 1.48-2.73 (m, 13 H), 3.09-3.76 (m, 4 H), 4.12 (q, J = 7.1 Hz, 2 H, OCH2), 7.26, (d, J = 8.2 Hz, 2 H, Ts), 7.66 (d, J = 8.2 Hz, 2 H, 
Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 14.2, 21.6, 22.5, 27.6, 27.7, 31.2, 32.1, 46.4, 60.8, 127.4, 129.7, 133.5, 137.3, 138.0, 143.5, 
167.9 ppm. ESI-HRMS for C19H26BrNO4S, [M+H]+ calc. 444.0893, found 444.0839. IR: ṽ = 2935 (-C-H), 1710 (C=O), 1350, 1230, 1155, 
1090, 1050 cm-1. 
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1-(tert-butyl) 3-ethyl 4-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)-5,6-dihydropyridine-1,3(2H)-dicarboxylate 7o 
 
Synthesis according to GP2: 250 mg (0.589 mmol) 1-(tert-butyl) 3-ethyl 4-((4-methylphenyl)sulfonamido)-5,6-dihydropyridine-1,3(2H)-
dicarboxylate S-4o, 407 mg (2.94 mmol) K2CO3, 0.597 mL (1.19 g, 5.89 mmol) 1,3-dibromopropane. Column chromatography 
hexanes/EtOAc 5:1 → 2:1 gave 198 mg (0.363 mmol, 62%) of 7o as a colorless oil. Rf = 0.15 (hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 
400 MHz) δ 1.29 (mc, 3 H, CH3), 1.48 (s, 9 H, Boc), 2.08 (m, 2 H, CH2), 2.16 (p, J = 6.6 Hz, 2 H, CH2), 2.42 (s, 3 H, CH3), 3.39-3.56 (m, 
6 H), 4.13 (mc, 2 H, CH2), 4.23 (br s, 2 H, CH2), 7.28 (d, J = 8.2 Hz, 2 H, Ts), 7.67 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 
MHz) δ 14.2, 21.6, 28.6, 29.8, 30.7, 32.4, 40.4, 44.6, 47.1, 61.2, 80.6, 127.6, 129.9, 130.2 137.4, 138.8, 143.9 154.6, 165.1 ppm. ESI-
HRMS for C16H18BrNO4S2, [M+NH4]+ calc. 562.1581, found 562.1571. IR: ṽ = 2980 (-C-H), 1700 (C=O), 1355, 1240, 1160 cm 1. 
methyl 2-((N-(3-iodopropyl)-4-methylphenyl)sulfonamido)thiophene-3-carboxylate 3a 
 
To a solution of 432 mg (1.00 mmol) alkylbromide 7a in 10.0 mL MeCN in an oven dried round bottom flask were added 749 mg 
(5.00 mmol) of NaI and the reaction mixture was heated to 60 °C for 18 h. After cooling to RT, the mixture was poured into brine/EtOAc 
and extracted with EtOAc (3x). The combined organic layers were washed with water (1x), dried over Na2SO4, and concentrated in 
vacuo. Column chromatography hexanes/EtOAc 4:1 → 3:1 gave 454 mg (0.947 mmol, 95%) of 3a as a colorless solid. Rf = 0.30 
(hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 400 MHz) δ 2.11 (p, J = 6.8 Hz, 2 H, CH2), 2.42 (s, 3 H, CH3), 3.25 (t, J = 6.8 Hz, 2 H, CH2), 
3.63 (s, 3 H, CH3), 3.73 (t, J = 6.8 Hz, 2 H, CH2), 7.16 (d, J = 5.9 Hz, 1 H, Ar), 7.27 (d, J = 8.2 Hz, 2 H, Ts), 7.31 (d, J = 5.9 Hz, 1 H, 
Ar), 7.58 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 2.2, 21.7, 32.9, 51.8, 53.8, 124.0, 128.0, 128.2, 129.6, 130.2, 
135.2, 144.1, 146.0, 162.1 ppm. IR: ṽ = 2950 (-C-H), 1715 (C=O), 1435, 1350, 1275, 1155, 1090 cm-1 
methyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)benzoate 8 
 
Synthesis according to GP2: 464 mg (1.52 mmol) methyl 2-((4-methylphenyl)sulfonamido)benzoate S-4p, 1.05 g (7.60 mmol) K2CO3, 
1.54 mL (3.07 g, 15.2 mmol) 1,3-dibromopropane. Column chromatography hexanes/EtOAc 5:1 → 2:1 gave 402 mg (0.943 mmol, 
62%) of 8 as colorless solid. Rf = 0.35 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 2.17 (mc, 2 H, CH2), 2.42 (s, 3 H, CH3), 3.50 
(t, J = 6.6 Hz, 2 H, CH2), 3.78 (br s, 2 H, CH2), 3.83 (s, 3 H, OCH3), 6.92 (d, J = 7.4 Hz, 1 H, Ar), 7.24 (d, J = 7.9 Hz, 2 H, Ts), 7.40 (p, 
J = 7.3 Hz, 2 H, Ar), (d, J = 7.9 Hz, 2 H, Ts), 7.86 (d, J = 7.2 Hz, 1 H, Ar) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.6, 30.7, 32.2, 50.5, 
52.3, 127.9, 128.3, 129.6, 131.5, 132.2, 133.2, 136.2, 138.5, 143.5, 166.6 ppm 
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methyl 4-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)nicotinate 9 
 
Synthesis according to GP2: 124 mg (0.405 mmol) methyl 4-((4-methylphenyl)sulfonamido)nicotinate S-4q, 280 mg (2.02 mmol) K2CO3, 
0.411 mL (0.817 g, 4.05 mmol) 1,3-dibromopropane. Column chromatography using pure EtOAc gave 116 mg (0.271 mmol, 67%) of 9 
as colorless oil. Rf = 0.10 (EtOAc). 1H-NMR (CDCl3, 400 MHz) δ 2.32 (p, J = 6.4 Hz, 2 H, CH2), 2.39 (s, 3 H, CH3), 3.34 (t, J = 5.9 Hz, 
2 H, CH2), 3.84 (s, 3 H, OCH3), 4.16 (t, J = 6.8 Hz, 2 H, CH2), 7.25 (d, J = 8.0 Hz, 2 H, Ts), 7.50 (d, J = 7.4 Hz, 1 H, Ar), 7.59 (d, J = 
7.4 Hz, 1 H, Ar), 7.91 (d, J = 8.0 Hz, 2 H, Ts), 8.09 (s, 1 H, Ar) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.6, 28.6, 32.8, 52.6, 55.8, 116.5, 
119.2, 165.2, 129.2, 139.4, 141.1, 142.0, 143.7, 159.1, 164.4 ppm 
methyl 2-(3-chloropropanamido)thiophene-3-carboxylate 10a 
 
In an oven dried round bottom flask was added 0.101 mL (134 mg, 1.00 mmol) of 3-chloropropanoyl chloride dropwise to a solution of 
157 mg (1.00 mmol) methyl 2-aminothiophene-3-carboxylate and 0.0807 mL (79.1mg, 1.00 mmol) pyridine in 4.0 mL of CH2Cl2. It was 
stirred at RT for 2 h and quenched by addition of of 1 N HCl. It was extracted with CH2Cl2 (3x), dried over Na2SO4, and concentrated 
in vacuo. Purification by column chromatography using hexanes/EtOAc 2:1 → 1:1 gave 233 mg (0.941 mmol, 94%) of 10a as a colorless 
solid. Rf = 0.30 (hexanes/EtOAc 1:1). 1H-NMR (CDCl3, 400 MHz) δ 2.95 (t, J = 6.5 Hz, 2 H, CH2), 3.80-3.93 (m, 5 H, CH2, OCH3), 6.73 
(d, J = 5.7 Hz, 1 H, Ar), 7.17 (d, J = 5.7 Hz, 1 H, Ar), 11.06 (s, 1 H, NH) ppm. 13C-NMR (CDCl3, 100 MHz) δ 39.2, 39.7, 51.9, 113.0, 
116.5, 123.8, 148.4, 166.1, 166.7 ppm. 
methyl 2-(3-chlorobutanamido)thiophene-3-carboxylate 10b 
 
In an oven dried round bottom flask was added 0.112 mL (142 mg, 1.00 mmol) of 4-chlorobutanoyl chloride dropwise to a solution of 
157 mg (1.00 mmol) methyl 2-aminothiophene-3-carboxylate and 0.0807 mL (79.1mg, 1.00 mmol) pyridine in 4.0 mL of CH2Cl2. It was 
stirred at RT for 2 h and quenched by addition of of 1 N HCl. It was extracted with CH2Cl2 (3x), dried over Na2SO4, and concentrated 
in vacuo. Purification by column chromatography using hexanes/EtOAc 3:1 → 1:1 gave 243 mg (0.928 mmol, 93%) of 10b as a colorless 
oil. Rf = 0.30 (hexanes/EtOAc 1:1). 1H-NMR (CDCl3, 400 MHz) δ 2.23 (p, J = 6.6 Hz, 2 H, CH2), 2.70 (t, J = 7.1 Hz, 2 H, CH2), 3.65 (t, 
J = 6.2 Hz, 2 H, CH2), 3.88 (s, 3 H, OCH3), 6.73 (d, J = 5.7 Hz, 1 H, Ar), 7.18 (d, J = 5.7 Hz, 1 H, Ar), 11.01 (s, 1 H, NH) ppm. 13C-NMR 
(CDCl3, 100 MHz) δ 27.7, 33.4, 44.2, 51.9, 112.6, 116.2, 123.8, 148.7, 166.1, 169.0 ppm. 
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Photocatalytic Smiles Reactions 
 
General procedure for the one-pot Finkelstein/photocatalytic Smiles reaction (GP3): To 0.10 mmol of alkylbromides 7 in a 2-dram-
vial equipped with a stir bar was added 0.300 mL of a freshly prepared solution of NaI in MeCN (0.167 M, 0.0500 mmol), 0.149 mL of 
[Ir(ppy)2(dtbbpy)]PF6 I in MeCN (6.71 mM, 1.00 µmol) and 51.0 µL iPr2NEt (38.8 mg, 0.300 mmol). To reactions run at 0.05 M was 
added 1.5 mL of MeCN. The reaction vessel was sealed, heated to 60 °C using an oil bath and irradiated by one Kessil H350 lamp for 
24 h. The solvent was removed under reduced pressure and the Smiles products 2 was purified by column chromatography using silica 
and hexanes/EtOAc. 
 
Figure S2. Experimental setup of Finkelstein/Smiles reaction. 
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methyl 2-(3-((4-methylphenyl)sulfonamido)propyl)thiophene-3-carboxylate 2a 
 
Synthesis according to GP3: 43.2 mg (0.100 mmol) methyl 2-((4-methylphenyl)sulfonamido)thiophene-3-carboxylate 7a, column 
chromatography hexanes/EtOAc 3:1 → 2:1 gave 33.6 mg (0.0951 mmol, 95%) of 2a as a colorless oil. Rf = 0.25 (hexanes/EtOAc 2:1). 
1H-NMR (CDCl3, 400 MHz) δ 1.84 (p, J = 6.9 Hz, 2 H, CH2), 2.40 (s, 3 H, Me), 2.95 (q, J = 6.4 Hz, 2 H, CH2), 3.17 (t, J = 7.3 Hz, 2 H, 
CH2), 3.83 (s, 3 H, OMe), 5.24 (t, J = 6.2 Hz, 1 H, NH), 7.02 (d, J = 5.4 Hz, 1 H, Ar), 7.27 (d, J = 8.2 Hz, 2 H, Ts), 7.32 (d, J = 5.4 Hz, 
1 H, Ar), 7.73 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.6, 25.8, 31.6, 42.0, 51.8, 122.1, 127.2, 128.1, 129.1, 129.7, 
137.3, 143.3, 153.6, 164.2 ppm. ESI-HRMS for C16H19NO4S2, [M+H]+ calc. 354.0828, found 354.0836. IR: ṽ = 3275 (N-H), 2945 (-C-
H), 1705 (C=O), 1435, 1325, 1260, 1155, 1095 cm-1. 
methyl 2-(3-((4-(trifluoromethyl)phenyl)sulfonamido)propyl)thiophene-3-carboxylate 2b  
 
Synthesis according to GP3: 48.6 mg (0.100 mmol) methyl 2-((N-(3-bromopropyl)-4-(trifluoromethyl)phenyl)sulfonamido)thiophene-3-
carboxylate 7b, concentration of reaction mixture 0.05 M, column chromatography hexanes/EtOAc 10:1 → 2:1 gave 20.5 mg 
(0.0503 mmol, 50%) of 2b as a colorless oil. Rf = 0.30 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.87 (p, J = 6.7 Hz, 2 H, 
CH2), 3.00 (q, J = 6.2 Hz, 2 H, CH2), 3.20 (t, J = 7.1 Hz, 2 H, CH2), 3.85 (s, 3 H, OCH3), 5.56 (mc, 1 H, NH), 7.05 (d, J = 5.4 Hz, 1 H, 
Ar), 7.32 (d, J = 5.4Hz, 1 H, Ar), 7.76 (d, J = 8.2 Hz, 2 H, Ar), 7.99 (d, J = 8.2 Hz, 2 H, Ar) ppm. 13C-NMR (CDCl3, 100 MHz) δ 25.4, 
31.7, 41.8, 52.0, 122.4, 123.4 (JC,F = 273 Hz), 126.3, 127.6, 128.2, 129.1, 134.3 (JC,F = 32.7 Hz), 144.2, 153.4, 164.5 ppm. ESI-HRMS 
for C16H16F3NO4S2, [M+H]+ calc. 408.0546, found 408.0542. IR: ṽ = 3280 (N-H), 2925 (-C-H), 1710 (C=O), 1320, 1255, 1160, 1130, 
1060 cm-1. 
methyl 2-(3-((tert-butoxycarbonyl)amino)propyl)thiophene-3-carboxylate 2c 
 
Synthesis according to GP3: 43.2 mg (0.100 mmol) methyl 2-((3-bromopropyl)(tert-butoxycarbonyl)amino)thiophene-3-carboxylate 7c, 
concentration of reaction mixture 0.05 M. After 24 h of reaction time the crude reaction mixture showed signals, that likely belong to 
spiro compound S-5 the solvent was removed, and the residue was dissolved in 2 mL of EtOAc and 2 mL of 1 N aqueous HCl was 
added. The biphasic mixture was stirred vigorously for 3 h, and then poured into sat. NaHCO3/EtOAc. It was extracted with EtOAc (3x), 
dried over Na2SO4 and concentrated. Column chromatography hexanes/EtOAc 5:1 → 3:1 gave 20.1 mg (0.0671 mmol, 67%) of 2c as 
a colorless oil. Rf = 0.25 (hexanes/EtOAc) 1H-NMR (CDCl3, 400 MHz) δ 1.45 (s, 9 H, Boc), 1.88 (p, J = 7.1 Hz, 2 H, CH2), 3.17 (mc, 2 
H, CH2), 3.23 (t, J = 7.5 Hz, 2 H, CH2), 3.84 (s, 3 H, OCH3), 4.83, (br s, 1 H, NH), 7.04, (d, J = 5.2 Hz, 1 H, Ar), 7.37 (d, J = 5.2 Hz, 1 
H, Ar) ppm. 13C-NMR (CDCl3, 100 MHz) δ 26.6, 28.6, 32.0, 40.0, 51.6, 79.3, 121.8, 128.0, 129.4, 154.3, 156.1, 164.1 ppm. ESI-HRMS 
for C14H21NO4S, [M+H]+ calc. 300.1264, found 300.1262. IR: ṽ = 35370 (N-H), 2975 (-C-H), 1695 (C=O), 1530, 1260, 1165 cm-1. 





Figure S3. Top: 1H-NMR of crude reaction mixture of Finkelstein/Smiles reaction of 7c prior to acidic treatment, showing signals of 
proposed side product S-5; bottom: after acidic treatment. 




methyl 2-(4-((4-methylphenyl)sulfonamido)butyl)thiophene-3-carboxylate 2d 
 
Synthesis according to GP3: 44.6 mg (0.100 mmol) methyl 2-((N-(3-bromobutyl)-4-methylphenyl)sulfonamido)thiophene-3-carboxylate 
7d, concentration of reaction mixture 0.05 M, column chromatography hexanes/EtOAc 4:1 → 3:1 gave 31.4 mg (0.0854 mmol, 85%) of 
2d as a colorless oil. Rf = 0.25 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.51-1.61 (m, 2 H, CH2), 1.63-1.72 (m, 2 H CH2), 
2.42 (s, 3 H, CH3), 3.00 (q, J = 6.6 Hz, 2 H, CH2), 3.10 (mc, 2 H, CH2), 4.71-4.80 (m, 1 H, NH), 7.01 (d, J = 5.4Hz, 1 H, Ar), 7.29 (d, J = 
8.2 Hz, 2 H, Ts), 7.36 (d, J = 5.4 Hz, 1 H, Ar), 7.75 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.7, 28.4, 28.5, 29.0, 
42.6, 51.7, 121.6, 127.2, 127.5, 129.3, 129.8, 137.2, 143.4, 154.7, 164.1 ppm. ESI-HRMS for C17H21NO4S2, [M+H]+ calc. 368.0985, 
found 368.0985. IR: ṽ = 3275 (N-H), 2945 (-C-H), 1705 (C=O), 1435, 1325, 1260, 1155, 1095 cm-1. 
methyl 2-(2-(((4-methylphenyl)sulfonamido)methyl)allyl)thiophene-3-carboxylate 2e  
 
Synthesis according to GP3: 38.0 mg (0.0855 mmol) methyl 2-((N-(2-(bromomethyl)allyl)-4-methylphenyl)sulfonamido)thiophene-3-
carboxylate 7e, column chromatography hexanes/EtOAc 2:1 → 1:1 gave 18.4 mg (0.0503 mmol, 59%) of 2e as a colorless oil. Rf = 0.20 
(hexnes/EtOAc 1:1). 1H-NMR (CDCl3, 400 MHz) δ 2.40 (s, 3 H, CH3), 2.53 (t, J = 6.3 Hz, 1 H, NH), 3.61 (s, 3 H, OCH3), 4.23 (d, J = 5.7 
Hz, 2 H, CH2), 4.27 (s, 2 H, CH2), 4.86 (s, 1 H, =CH2), 5.06 (s, 1 H, =CH2), 7.11 (d, J = 5.8 Hz, 1 H, Ar), 7.21-7.29 (m, 3 H, Ar, Ts), 7.56 
(d, J = 8.1 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.7, 51.9, 55.4, 63.7, 116.4, 123.8, 128.0, 128.2, 129.7, 129.8, 134.9, 
143.3, 144.3, 145.8, 162.4 ppm. IR: ṽ = 3525 (N-H), 2950 (-C-H), 1715 (C=O), 1440, 1350, 1275, 1160 cm-1. 
ethyl 4,5-dimethyl-2-(3-((4-methylphenyl)sulfonamido)propyl)thiophene-3-carboxylate 2f 
 
Synthesis according to GP3: 47.4 mg (0.100 mmol) ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)-4,5-dimethylthiophene-
3-carboxylate 7f, column chromatography hexanes/EtOAc 3:1 → 2:1 gave 32.5 mg (0.0822 mmol, 82%) of 2f as a colorless oil. Rf = 0.30 
(hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.35 (t, J = 7.1 Hz, 3 H, CH3), 1.79 (p, J = 6.8 Hz, 2 H, CH2), 2.17 (s, 3 H, CH3), 
2.25 (s, 3 H, CH3), 2.41 (s, 3 H, CH3), 2.91-3.03 (m, 4 H, CH2), 4.31 (q, J = 7.1 Hz, 2 H, CH2), 5.26 (t, J = 6.2 Hz, 1 H, NH), 7.27 (d, J 
= 8.2 Hz, 2 H, Ts), 7.73 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.7, 51.9, 55.4, 63.7, 116.4, 123.8, 128.0, 128.2, 
129.7, 129.8, 134.9, 143.3, 144.3, 145.8, 162.4 ppm. ESI-HRMS for C19H25NO4S2, [M+H]+ calc. 396.1298, found 396.1299. IR: ṽ = 
3275 (N-H), 2925 (-C-H), 1700 (C=O), 1325, 1260, 1155 1090 cm-1. 
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ethyl 4-methyl-2-(3-((4-methylphenyl)sulfonamido)propyl)thiophene-3-carboxylate 2g 
 
Synthesis according to GP3: 46.0 mg (0.100 mmol) ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)-4-methylthiophene-3-
carboxylate 7g, column chromatography hexanes/EtOAc 3:1 → 2:1 gave 34.3 mg (0.0899 mmol, 90%) of 2g as a colorless oil. Rf = 0.30 
(hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.35 (t, J = 7.1 Hz, 3 H, CH3), 1.83 (p, J = 6.9 Hz, 2 H, CH2), 2.32 (s, 3 H, CH3) 
2.41 (s, 3 H, CH3), 2.95 (q, J = 9.6 Hz, 2 H, CH2), 3.07 (t, J = 7.3 Hz, 2 H, CH2), 4.31 (q, J = 7.1 Hz, 2 H, CH2) 5.18-5.29 (m, 1 H, NH), 
6.67 (s, 1 H, Ar), 7.27 (d, J = 8.2 Hz, 1 H, Ts), 7.73 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 14.4, 17.6, 21.6 (CH3), 
26.7, 31.6, 42.0, 60.7, 51.8, 119.0, 127.2, 128.5, 129.7, 137.4, 139.1, 143.3, 153.1, 164.7 ppm. ESI-HRMS for C18H23NO4S2, [M+H]+ 
calc. 382.1141, found 382.1141. IR: ṽ = 3270 (N-H), 2925 (-C-H), 1700 (C=O), 1325, 1255, 1155, 1090 cm-1. 
methyl 2-(3-((4-methylphenyl)sulfonamido)propyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate 2h 
 
Synthesis according to GP3: 48.6 mg (0.100 mmol) methyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)-4,5,6,7-
tetrahydrobenzo[b]thiophene-3-carboxylate 7h, column chromatography hexanes/EtOAc 3:1 → 2:1 gave 34.3 mg (0.0899 mmol, 90%) 
of 2h as a colorless oil. Rf = 0.35 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.58-1.80 (m, 6 H, CH2), 2.32 (s, 3 H, CH3), 2.55 
(t, J = 5.6 Hz, 2 H, CH2), 2.61 (t, J = 5.8 Hz, 2 H, CH2), 2.87 (q, J = 6.4 Hz, 2 H, CH2), 2.94 (t, J = 7.2 Hz, 2 H, CH2), 3.73 (s, 3 H, OCH3), 
5.17 (t, J = 6.2 Hz, 1 H, NH), 7.19 (d, J = 8.2 Hz, 2 H, Ts), 7.65 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.8, 22.8, 
23.1, 25.1, 26.2, 26.6, 31.6, 41.9, 51.5, 127.2, 127.6, 129.7, 133.6, 135.7, 137.4, 143.2, 149.7, 165.1 ppm. ESI-HRMS for 
C20H25F3NO4S2, [M+H]+ calc. 408.1298, found 408.1296. IR: ṽ = 3275 (N-H), 2930 (-C-H), 1705 (C=O), 1325, 1155, 1095 cm-1. 
5-(tert-butyl) 3-ethyl 2-(3-((4-methylphenyl)sulfonamido)propyl)-6,7-dihydrothieno[3,2-c]pyridine-3,5(4H)-dicarboxylate 2i 
 
Synthesis according to GP3: 58.8 mg (0.0977 mmol) 5-(tert-butyl) 3-ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)-6,7-
dihydrothieno[3,2-c]pyridine-3,5(4H)-dicarboxylate 7i, column chromatography hexanes/EtOAc 3:1 → 2:1 gave 34.4 mg (0.0658 mmol, 
67%) of 2i as a colorless oil. Rf = 0.25 (hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.34 (t, J = 7.1 Hz, 3 H, CH3), 1.47 (s, 9H, 
Boc), 1.81 (p, J = 6.8 Hz, 2 H, CH2), 2.41 (s, 3 H, OCH3), 2.82 (mc, 2 H, CH2), 2.96 (q, J = 6.4 Hz, 2 H, CH2), 3.08 (t, J = 7.2 Hz, 2 H, 
CH2), 3.61 (t, J = 5.5 Hz, 2 H, CH2), 4.29 (q, J = 7.1 Hz, 2 H, OCH2), 4.49 (s, 2 H, CH2), 5.21 (mc, 1 H, NH), 7.27 (d, J = 8.2 Hz, 2 H, 
Ts), 7.73 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 14.4, 21.6, 26.4, 27.1, 28.6, 31.7, 41.3, 42.1, 43.2, 60.7, 80.3, 
127.3, 127.5, 129.7, 130.1, 134.9, 137.8, 143.3, 151.0, 154.7, 164.1 ppm. ESI-HRMS for C25H34N2O6S2, [M+NH4]+ calc. 540.2197, 
found 540.2188. IR: ṽ = 3265 (N-H), 2980 (-C-H), 1690 (C=O), 1415, 1325, 1235, 1155, 1095, 1020 cm-1. 





Synthesis according to GP3: 39.9 mg (0.100 mmol) N-(3-bromopropyl)-N-(3-cyanothiophen-2-yl)-4-methylbenzenesulfonamide 7j, 
column chromatography hexanes/EtOAc 3:1 → 1:1 gave 25.8 mg (0.0805 mmol, 81%) of 2j as a colorless oil. Rf = 0.25 (hexanes/EtOAc 
3:2). 1H-NMR (CDCl3, 400 MHz) δ 1.90 (p, J = 7.2 Hz, 2 H, CH2), 2.42 (s, 3 H, CH3), 2.93-3.09 (m, 4 H, CH2), 4.84_4.94 (m, 1 H, NH), 
7.09 (d, J = 5.3 Hz, 1 H, Ar), 7.17 (d, J = 5.3 Hz, 1 H, Ar), 7.31 (d, J = 8.0 Hz, 2 H, Ts), 7.74 (d, J = 8.0 Hz, 2 H, Ts) ppm. 13C-NMR 
(CDCl3, 100 MHz) δ 21.7, 26.4, 31.3, 42.3, 108.7, 115.0, 124.7, 127.2, 128.4, 129.9, 136.8, 143.7, 155.5 ppm. ESI-HRMS for 
C15H16N2O2S2, [M+H]+ calc. 321.0726, found 321.0726. IR: ṽ = 3270 (N-H), 2925 (-C-H), 2225 (C≡N), 1325, 1155, 1090 cm-1. 
methyl 3-(3-((4-methylphenyl)sulfonamido)propyl)thiophene-2-carboxylate 2k 
 
Synthesis according to GP3: 43.2 mg (0.100 mmol) methyl 3-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)thiophene-2-
carboxylate 7k, column chromatography hexanes/EtOAc 3:1 → 3:2 gave 27.0 mg (0.0764 mmol, 76%) of 2k as a colorless oil. Rf = 0.20 
(hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.78 (p, J = 6.8 Hz, 2 H, CH2), 2.41 (s, 3 H, CH3), 2.91 (q, J = 6.4 Hz, 2 H, CH2), 
2.99 (t, J = 7.2 Hz, 2 H, CH2), 3.84 (s, 3 H, OCH3), 5.11-5.24 (m, 1 H, NH), 6.87 (d, J = 5.0 Hz, 1 H, Ar), 7.27 (d, J = 8.2 Hz, 2 H, Ts), 
7.39 (d, J = 5.0 Hz, 1 H, Ar), 7.73 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.6, 26.0, 30.2, 42.1, 52.1, 126.7, 127.2, 
129.7, 130.7, 131.0, 137.4, 143.3, 149.8, 163.4 ppm. ESI-HRMS for C16H19NO4S2, [M+H]+ calc. 354.0828, found 354.0828. IR: ṽ = 
3280 (N-H), 2950 (-C-H), 1705 (C=O), 1435, 1325, 1260, 1160, 1080 cm-1. 
N-(3-(2-methoxyphenyl)propyl)-4-methylbenzenesulfonamide 2l 
 
Synthesis according to GP3: 39.8 mg (0.100 mmol) N-(3-bromopropyl)-N-(2-methoxyphenyl)-4-methylbenzenesulfonamide 7l, 
concentration 0.05 M of starting material, column chromatography hexanes/EtOAc 5:1 → 1:1 gave 14.2 mg (0.0445 mmol, 45%) of 2l 
as a colorless oil. Rf = 0.55 (hexanes/EtOAc 1:1). 1H-NMR (CDCl3, 400 MHz) δ 1.73 (p, J = 7.0 Hz, 2 H, CH2), 2.42 (s, 3 H, CH3), 2.60 
(t, J = 7.3 Hz, 2 H, CH2), 2.93 (q, J = 6.6 Hz, 2 H, CH2), 3.79 (s, 3 H, OCH3), 4.58 (t, J = 5.9 Hz, 1 H, NH), 6.82 (d, J = 8.2 Hz, 1 H, Ar), 
6.85 (t, J = 7.4 Hz, 1 H, Ar), 7.01 (d, J = 7.4 Hz, 1 H, Ar), 7.17 (t, J = 7.8 Hz, 1 H, Ar), 7.29 (d, J = 8.0 Hz, 2 H, Ts), 7.72 (d, J = 8.0 Hz, 
2 H, Ts) ppm. 13C-NMR (CDCl3, 100 MHz) δ 21.7, 26.9, 29.9, 42.6, 55.4, 110.5, 120.8, 127.2, 127.6, 129.2, 129.8, 130.2, 137.3, 143.4, 
157.4 ppm. ESI-HRMS for C17H21NO3S, [M+H]+ calc. 320.1315, found 320.1314. IR: ṽ = 3280 (N-H), 2922 (-C-H), 1495, 1325, 1245, 
1155, 1095 cm-1. 
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ethyl 2-(3-((4-methylphenyl)sulfonamido)propyl)cyclopent-1-ene-1-carboxylate 2m 
 
Synthesis according to GP3: 43.0 mg (0.100 mmol) ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)cyclopent-1-ene-1-
carboxylate 7m, column chromatography hexanes/EtOAc 3:1 → 1:1 gave 32.7 mg (0.0930 mmol, 93%) of 2m as a colorless oil. 
Rf = 0.15 (hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 400 MHz) δ 1.28 (t, J = 7.1 Hz, 3 H, CH3), 1.65 (p, J = 6.6 Hz, 2 H, CH2), 1.73 (p, 
J = 7.5 Hz, 2 H, CH2), 2.35 (t, J = 7.5 Hz, 2 H, CH2), 2.41 (s, 3 H, CH3), 2.49-2.59 (m, 4 H, CH2), 2.87 (q, J = 6.3 Hz, 2 H, CH2), 4.19 
(q, J = 7.1 Hz, 2 H, OCH2), 5.60-5.69 (m, 1 H, NH), 7.27 (d, J = 8.2 Hz, 2 H, Ts), 7.72 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 
100 MHz) δ 14.4, 21.5, 21.6, 26.1, 27.0, 33.6, 37.8, 41.9, 60.3, 127.1, 129.1, 129.6, 137.6, 143.1, 158.1, 166.8 ppm. ESI-HRMS for 
C18H25NO4S, [M+H]+ calc. 352.1577, found 352.1576. IR: ṽ = 3275 (N-H), 2925 (-C-H), 1685 (C=O), 1325, 1260, 1155, 1090 cm-1. 
ethyl 2-(3-((4-methylphenyl)sulfonamido)propyl)cyclohex-1-ene-1-carboxylate 2n 
 
Synthesis according to GP3: 44.4 mg (0.100 mmol) ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)cyclohex-1-ene-1-
carboxylate 7n, column chromatography hexanes/EtOAc 4:1 → 2:1 gave 29.9 mg (0.0818 mmol, 82%) of 2n as a colorless oil. Rf = 0.15 
(hexanes/EtOAc 3:1). 1H-NMR (CDCl3, 400 MHz) 1.28 (t, J = 7.1 Hz, 3 H, CH3), 1.53 (mc, 4 H, CH2), 1.65 (p, J = 6.2 Hz, 2 H, CH2), 
1.99 (m, 2 H, CH2), 2.19 (m, 2 H, CH2), 2.33 (t, J = 7.2 Hz, 2 H, CH2), 2.41 (s, 3 H, CH3), 2.89 (q, J = 6.2 Hz, 2 H, CH2), 4.18 (q, J = 7.1 
Hz, 2 H, OCH2), 5.65 (t, J = 6.2 Hz, 1 H, NH), 7.27 (d, J = 8.2 Hz, 2 H, Ts), 7.73 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 
MHz) δ 14.4, 21.6, 22.1, 22.3, 26.6, 27.3, 30.8, 31.5, 42.1, 60.5, 126.1, 127.2, 129.6, 137.5, 143.1, 147.6, 169.5 ppm. ESI-HRMS for 
C19H27NO4S, [M+H]+ calc. 366.1734, found 366.1727. IR: ṽ = 3275 (N-H), 2930 (-C-H), 1705 (C=O), 1325, 1230, 1155, 1090 cm-1. 
1-(tert-butyl) 3-ethyl 4-(3-((4-methylphenyl)sulfonamido)propyl)-5,6-dihydropyridine-1,3(2H)-dicarboxylate 2o 
 
Synthesis according to GP3: 54.5 mg (0.100 mmol) ethyl 2-((N-(3-bromopropyl)-4-methylphenyl)sulfonamido)cyclohex-1-ene-1-
carboxylate 7o, column chromatography hexanes/EtOAc 4:1 → 1:1 gave 32.0 mg (0.0686 mmol, 69%) of 2o as a colorless oil. Rf = 0.15 
(hexanes/EtOAc 2:1). 1H-NMR (CDCl3, 400 MHz) δ 1.28 (t, J = 7.2 Hz, 3 H, CH3), 1.46 (s, 9 H, Boc), 1.66 (m, 2 H, CH2), 2.14 (mc, 2 H, 
CH2), 2.41 (s, 3 H, CH3), 2.47 (t, J = 7.2 Hz, 2 H, CH2), 2.91 (q, J = 6.2 Hz, 2 H, CH2), 3.39 (t, J = 5.7 Hz, 2 H, CH2), 4.04 (br s, 2 H, 
CH2), 4.19 (mc, 2 H, OCH2), 5.42 (br s, 1 H, NH), 7.28 (d, J = 8.2 Hz, 2 H, Ts), 7.73 (d, J = 8.2 Hz, 2 H, Ts) ppm. 13C-NMR (CDCl3, 100 
MHz) δ 14.3, 21.6, 27.8, 28.6, 31.0, 31.4, 39.7, 42.4, 43.6, 60.7, 80.1, 123.6, 127.2, 129.7, 137.8, 143.2, 149.1, 154.7, 166.5 ppm. ESI-
HRMS for C23H34N2O6S, [M+H]+ calc. 467.2210, found 467.2206. IR: ṽ = 3275 (N-H), 2980 (-C-H), 1690 (C=O), 1240, 1155, 1095 cm-
1. 
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Synthesis of tetrahydrothienoazepinone 1 
 
In a round bottom flask open to air 181 mg (0.605 mmol) of methyl 2-(3-((tert-butoxycarbonyl)amino)propyl)thiophene-3-carboxylate 2c 
were dissolved in 4.5 mL of CH2Cl2 and 0.756 mL of a 4.0 M solution of HCl (3.02 mmol) in 1,4-dioxane were added and it was stirred 
for 6 h at RT. The reaction mixture was added to sat. NaHCO3/EtOAc and extracted with EtOAc (3x), dried over Na2SO4 and 
concentrated in vacuo. The residue was redissolved in 6.0 mL of MeOH, 49.1 mg (0.909 mmol) of NaOMe were added and it was 
heated to 60 °C for 24 h. The reaction mixture was poured into water, extracted with EtOAc (3x), dried over Na2SO4 and concentrated 
in vacuo. Column chromatography (CH2Cl2/MeOH 19:1) gave 58.4 mg (0.349 mmol, 58%) of 5,6,7,8-tetrahydro-4H-thieno[3,2-
c]azepin-4-one 1 as a colorless solid. Rf = 0.15 (CH2Cl2/MeOH 19:1). 1H-NMR (CDCl3, 400 MHz) 2.10 (p, J = 6.4 Hz, 2 H, CH2), 3.09 
(t, J = 7.1 Hz, 2 H, CH2), 3.30 (m, 2 H, CH2), 7.04 (d, J = 5.3 Hz, 1 H, Ar), 7.28-7.42 (m, 2 H, Ar, NH) ppm. 13C-NMR (CDCl3, 100 MHz) 
δ 26.9, 29.4, 41.2, 122.4, 129.8, 133.6, 145.8, 169.3 ppm. ESI-HRMS for C8H10NOS, [M+H]+ calc. 168.0478, found 168.0479. 
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